QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2022     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Identified potential pathogenic variants of BARD1 in 1449 Chinese high-risk breast cancer patients. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Wang, Rong;  Ye, Weiwu;  Chen, Zhanhong;  Shao, Xiying;  Cao, Wenming 收藏  |  浏览/下载：5/0  |  提交时间：2022/12/23 Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Chen, Zhanhong;  Wang, Xiaojia;  Huang, Jian;  Zheng, Yabing;  Shao, Xiying 收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23 Development of a new HRD algorithm which was highly associated with anthracyclinecontaining neoadjuvant chemotherapy. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Cao, Wen-Ming;  Pan, Jiani;  Wang, Xiaojia;  Lou, Feng;  Li, Mingwei 收藏  |  浏览/下载：9/0  |  提交时间：2022/12/23 BRCANet: A deep hybrid network in predicting BRCA1/2 gene mutation of breast cancer with dynamic contrast-enhanced breast MRI. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Cao, Wen-Ming;  Wang, Xiaojia;  Liu, Jian;  Wang, Lili;  Zhang, Xiaodong 收藏  |  浏览/下载：12/0  |  提交时间：2022/12/23